#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute hepatic failure Immune-mediated renal disorder Subdural haematoma Hyperphagia Osteopetrosis Cytokine release syndrome Thrombotic thrombocytopenic purpura NTRK gene fusion overexpression Adult T-cell lymphoma/leukaemia refractory Warm autoimmune haemolytic anaemia Metastases to peritoneum Polyneuropathy Ovarian epithelial cancer Cortical dysplasia Ichthyosis More trials…

    Learn about Rare Diseases

    Angiosarcoma – Diagnostics Alagille syndrome – Diagnostics Antisynthetase syndrome – Treatment Myelodysplastic syndrome – Treatment Ocular melanoma – Trials in Disease Soft tissue sarcoma – Basic Information Behcet’s syndrome – Diagnostics Ewing’s sarcoma recurrent Breast angiosarcoma metastatic – Treatment Alternating hemiplegia of childhood – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amoxicillin Sodium Dabrafenib GRNA-001 Magnesium Oxide, Light Vinorelbine Ertapenem Sodium Human Cancellous Bone Nofazinlimab Aldesleukin Sebetralstat Bgb-15025 Citrate Aavanc80-5'Hotof Bi 1839100 Oxycodone Hydrochloride Cobamamide Vedolizumab Quemliclustat Capivasertib Dasatinib Granisetron More therapies…

    Learn about Your Condition

    Rubella Psychogenic seizure Essential hypertension Critical illness Obliterative bronchiolitis Paresis Follicular lymphoma stage III Hyperadrenocorticism Kaposi's sarcoma Systemic candida Diabetic retinal oedema Tendon disorder Fibrosarcoma metastatic Malignant mast cell neoplasm Deep vein thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)

    Not recruiting

    2 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    Investigated Drugs:
    • Gsk4532990A
    Belgium France Greece Italy Spain

  • Study on the Safety and Effectiveness of 2-Hydroxyoleic Acid and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • IDROXIOLEIC ACID
    France Italy Spain

  • Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Emtansine
    Austria Belgium Bulgaria Czechia Denmark France +8

  • Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Olaparib
    Austria Belgium France Germany Hungary Iceland +6

  • Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • ALKYLATING AGENTS
    • ANTIMETABOLITES
    • Imetelstat Sodium
    Austria Belgium Bulgaria Denmark France Germany +5

  • Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Salbutamol Sulfate
    • Fluticasone Propionate
    Bulgaria Czechia Denmark Germany Greece Hungary +6

  • Study of Pembrolizumab, Lenvatinib, and Chemotherapy for First-Line Treatment in Extensive-Stage Small Cell Lung Cancer Patients

    Not recruiting

    2 1 1 1
    Spain

  • Study of Chemotherapy and Nivolumab Before and After Surgery for Patients with Non-Small Cell Lung Cancer in the Upper Lung Area

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancoast’s tumour
    Spain

  • Study on Lasmiditan for Treating Migraine in Children Aged 6 to 17

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lasmiditan
    Belgium France Germany Italy The Netherlands Romania +1

  • Study of Azenosertib (ZN-c3) for Women with Recurrent or Persistent Uterine Serous Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Papillary serous endometrial carcinoma
    Investigated Drugs:
    • Aprepitant
    • Granisetron
    • Olanzapine
    France Italy Spain
Previous Page
1 … 18 19 20 21 22 … 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!